ZhuZhou QianJin Pharmaceutical Co.,Ltd

Symbol: 600479.SS

SHH

10.91

CNY

Market price today

  • 17.6303

    P/E Ratio

  • 12.5175

    PEG Ratio

  • 4.56B

    MRK Cap

  • 0.03%

    DIV Yield

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479-SS) Stock Price & Analysis

Shares Outstanding

418.51M

Gross Profit Margin

0.46%

Operating Profit Margin

0.12%

Net Profit Margin

0.07%

Return on Assets

0.06%

Return on Equity

0.12%

Return on Capital Employed

0.15%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Shun Jian
Full-time employees:5133
City:Zhuzhou
Address:No. 801 Zhuzhou Avenue
IPO:2004-03-12
CIK:

ZhuZhou QianJin Pharmaceutical Co.,Ltd produces and sells pharmaceutical products in China. The company provides gynecology, pediatrics, beauty, antimicrobial, circulatory, endocrine, specialty, digestive, nervous, and cardiovascular products, as well as traditional Chinese medicines It offers its products in various forms, including tablets, capsules, granules, pills, decoctions, powders, and solution. The company also provides ginger tea; feminine hygiene products; and wine. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1993 and is headquartered in Zhuzhou, China.

General Outlook

In simple terms, ZhuZhou QianJin Pharmaceutical Co.,Ltd has 418.507 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.461% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.121%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.073%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.059% return, is a testament to ZhuZhou QianJin Pharmaceutical Co.,Ltd's adeptness in optimizing resource deployment. ZhuZhou QianJin Pharmaceutical Co.,Ltd's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.121%. Furthermore, the proficiency of ZhuZhou QianJin Pharmaceutical Co.,Ltd in capital utilization is underscored by a remarkable 0.147% return on capital employed.

Stock Prices

ZhuZhou QianJin Pharmaceutical Co.,Ltd's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $10.96, while its low point bottomed out at $10.76. This variance in figures offers investors a lucid insight into the roller-coaster ride that is ZhuZhou QianJin Pharmaceutical Co.,Ltd's stock market.

Liquidity Ratios

Analyzing 600479.SS liquidity ratios reveals its financial health of the firm. The current ratio of 227.95% gauges short-term asset coverage for liabilities. The quick ratio (189.34%) assesses immediate liquidity, while the cash ratio (129.58%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio227.95%
Quick Ratio189.34%
Cash Ratio129.58%

Profitability Ratios

600479.SS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 12.09% underscores its earnings before tax deductions. The effective tax rate stands at 14.25%, revealing its tax efficiency. The net income per EBT, 60.19%, and the EBT per EBIT, 99.68%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 12.13%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin12.09%
Effective Tax Rate14.25%
Net Income per EBT60.19%
EBT per EBIT99.68%
EBIT per Revenue12.13%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.28, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 392.80% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding189
Days of Inventory Outstanding95
Operating Cycle188.18
Days of Payables Outstanding115
Cash Conversion Cycle73
Receivables Turnover3.93
Payables Turnover3.16
Inventory Turnover3.83
Fixed Asset Turnover6.44
Asset Turnover0.81

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.74, and free cash flow per share, 0.64, depict cash generation on a per-share basis. The cash per share value, 4.53, showcases liquidity position. A payout ratio of 0.60 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.08, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.74
Free Cash Flow per Share0.64
Cash per Share4.53
Payout Ratio0.60
Operating Cash Flow Sales Ratio0.08
Free Cash Flow to Operating Cash Flow Ratio0.86
Cash Flow Coverage Ratio2.74
Short Term Coverage Ratio4.08
Capital Expenditure Coverage Ratio7.26
Dividend Paid and Capex Coverage Ratio1.53
Dividend Payout Ratio0.03

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 2.50%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.05, we discern the balance between debt and equity financing. The long-term debt to capitalization, 1.58%, and total debt to capitalization, 4.66%, ratios shed light on its capital structure. An interest coverage of 276.08 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio2.50%
Debt Equity Ratio0.05
Long Term Debt to Capitalization1.58%
Total Debt to Capitalization4.66%
Interest Coverage276.08
Cash Flow to Debt Ratio2.74
Company Equity Multiplier1.96

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 8.99, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.76, reflects the portion of profit attributed to each share. The book value per share, 5.66, represents the net asset value distributed per share, while the tangible book value per share, 6.57, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share8.99
Net Income Per Share0.76
Book Value Per Share5.66
Tangible Book Value Per Share6.57
Shareholders Equity Per Share5.66
Interest Debt Per Share0.28
Capex Per Share-0.10

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -5.66%, indicates top-line expansion, while the gross profit growth, 0.88%, reveals profitability trends. EBIT growth, 3.67%, and operating income growth, 3.67%, offer insights into operational profitability progression. The net income growth, 5.92%, showcases bottom-line expansion, and the EPS growth, 1.37%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-5.66%
Gross Profit Growth0.88%
EBIT Growth3.67%
Operating Income Growth3.67%
Net Income Growth5.92%
EPS Growth1.37%
EPS Diluted Growth4.11%
Weighted Average Shares Growth0.96%
Weighted Average Shares Diluted Growth0.96%
Dividends per Share Growth-41.09%
Operating Cash Flow Growth-39.59%
Free Cash Flow Growth-42.90%
10-Year Revenue Growth per Share66.69%
5-Year Revenue Growth per Share13.02%
3-Year Revenue Growth per Share3.73%
10-Year Operating CF Growth per Share178.74%
5-Year Operating CF Growth per Share14.45%
3-Year Operating CF Growth per Share-19.08%
10-Year Net Income Growth per Share124.13%
5-Year Net Income Growth per Share24.27%
3-Year Net Income Growth per Share6.83%
10-Year Shareholders Equity Growth per Share105.21%
5-Year Shareholders Equity Growth per Share16.66%
3-Year Shareholders Equity Growth per Share4.42%
10-Year Dividend per Share Growth per Share60.29%
5-Year Dividend per Share Growth per Share39.51%
3-Year Dividend per Share Growth per Share-30.03%
Receivables Growth-1.71%
Inventory Growth-10.83%
Asset Growth1.19%
Book Value per Share Growth6.80%
Debt Growth-6.06%
R&D Expense Growth30.97%
SGA Expenses Growth-1.13%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 2,669,472,964.74, captures the company's total value, considering both debt and equity. Income quality, 1.12, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.02, gauges operational efficiency, while the research and development to revenue, 3.92%, highlights investment in innovation. The ratio of intangibles to total assets, 5.40%, indicates the value of non-physical assets, and capex to operating cash flow, -9.93%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value2,669,472,964.74
Income Quality1.12
Sales General and Administrative to Revenue0.02
Research and Development to Revenue3.92%
Intangibles to Total Assets5.40%
Capex to Operating Cash Flow-9.93%
Capex to Revenue-1.16%
Capex to Depreciation-42.44%
Stock-Based Compensation to Revenue0.07%
Graham Number9.82
Return on Tangible Assets7.24%
Graham Net Net3.06
Working Capital1,972,677,059
Tangible Asset Value2,774,406,661
Net Current Asset Value1,864,357,673
Average Receivables975,457,941
Average Payables714,202,607.5
Average Inventory566,565,476
Days Sales Outstanding93
Days Payables Outstanding115
Days of Inventory On Hand95
ROIC15.76%
ROE0.13%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.04, and the price to book ratio, 2.04, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.25, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 17.18, and price to operating cash flows, 15.26, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.04
Price to Book Ratio2.04
Price to Sales Ratio1.25
Price Cash Flow Ratio15.26
Price Earnings to Growth Ratio12.52
Enterprise Value Multiple13.64
Price Fair Value2.04
Price to Operating Cash Flow Ratio15.26
Price to Free Cash Flows Ratio17.18
Price to Tangible Book Ratio1.90
Enterprise Value to Sales0.70
Enterprise Value Over EBITDA4.54
EV to Operating Cash Flow6.02
Earnings Yield7.04%
Free Cash Flow Yield8.77%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) on the SHH in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 17.630 in 2024.

What is the ticker symbol of ZhuZhou QianJin Pharmaceutical Co.,Ltd stock?

The ticker symbol of ZhuZhou QianJin Pharmaceutical Co.,Ltd stock is 600479.SS.

What is company IPO date?

IPO date of ZhuZhou QianJin Pharmaceutical Co.,Ltd is 2004-03-12.

What is company current share price?

Current share price is 10.910 CNY.

What is stock market cap today?

The market cap of stock today is 4556201470.000.

What is PEG ratio in 2024?

The current 12.518 is 12.518 in 2024.

What is the number of employees in 2024?

In 2024 the company has 5133.